Generics 1

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Tizanidine manufacturers

1 products found

Filters

Filters

Filters , active

Country of origin : Vietnam

Clear all

1 products found

tizanidine

Tablets 2 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Vietnam
GMP approvals
WHO
Manufacturer #21512
Founded in 1976, this company began as a merger of seven private pharmaceutical institutes to form a state-owned enterprise under the jurisdiction of the local health department. Over the years, it evolved to adapt to the changing economic landscape, becoming a joint stock company in 2001 as part of a broader strategy to diversify ownership and enhance business efficiency. Today, the company operates with a focus on leveraging its legacy and infrastructure to drive growth and employee investment, maintaining a strong presence in the pharmaceutical sector.

Want to see all 1 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription
Markets of interest: Tizanidine is prescribed to treat muscle spasms caused by conditions like multiple sclerosis, spinal cord injury, or muscle spasticity. The drug lowers muscle spasms by blocking nerve impulses (pain sensations) that are sent to the brain. This is a short-acting medication which belongs to a class of alpha-2-adrenergic agonists. The medication should be taken orally, only for daily activities that require relief from muscle spasms. The drug is available for sale in different forms such as capsules (at concentrations of 2mg, 4mg, and 6mg) and tablets from manufacturers in various countries including Y. The leading tizanidine manufacturers and distributors are based in India, Japan and the USA. Licensing and brand names Tizanidine was approved by the FDA for medical use in the United States in 1996 and available for sale as a generic medication. Tizanidine is marketed in some countries under the trade names Zanaflex or Tizanidine Hydrochloride. The leading Tizanidine suppliers and manufacturers are the Indian companies Sun Pharma and Dr. Reddy's. Other manufacturing companies from Turkey, Indonesia, Argentina, Czech Republic, Japan, and USA, have also successfully adapted to the demands of the global marketplace and produce a variant of the drug with Tizanidine as an active ingredient. Target supply price The wholesale acquisition cost of the tizanidine supply of 150 oral capsules in the United States ranges between 459 USD and 865 USD, depending on the drug concentrations in the capsules, 2mg, 4mg, or 6mg. The supply of 150 tables in the United States cost around 434 USD. The retail price of supply of 120 tablets of tizanidine in the EU is about 32 EUR. The medication wholesale prices and commercial terms can vary depending on the supplier. Information from manufacturers We provide a detailed list of the tizanidine manufacturers and suppliers that you are looking for. You can also find the dossier status of the drug that you order, and the GMP approvals of the different variants of the medication. The product description of all tizanidine suppliers contains essential information about the medication, including clinical data, stability zones, and a list of countries where tizanidine is already registered in. Manufacturers also specify the commercial terms of their offers, such as the market for which the offer is intended, deal type, dossier licensing fee, supply price, payment terms as well as delivery terms. Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified tizanidine suppliers and distributors enter our online marketplace, offering you a risk-free global B2B pharmaceutical sales platform.

Interested in becoming a subscriber?

Please provide the following information to receive an offer tailored to your business needs

  1. Number of company users for the subscription
  2. The rough number of products you would like to source in the 12 months
  3. Target market(s) for commercialisation